TITLE

The killer bug

AUTHOR(S)
Shnayerson, Michael
PUB. DATE
September 2002
SOURCE
Fortune;9/30/2002, Vol. 146 Issue 6, p149
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on a mutation of the Staphylococcus aureus (S. aureus) that is resistant to penicillin, methicillin, and vancomycin. Infection of a Michigan woman with a vancomycin-resistant strain; Effects of unstoppable infections in hospitals; Transmission of germs in hospitals; Vaccine from Nabi Biopharmaceuticals that may treat S. aureus; Gene mutations in S. aureus; Discussion that drug companies do not produce more antibiotics.
ACCESSION #
7356012

 

Related Articles

  • Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype. Begic, Damir; von Eiff, Christof; Tsuji, Brian T. // Journal of Antimicrobial Chemotherapy (JAC);May2009, Vol. 63 Issue 5, p977 

    : Objectives Staphylococcus aureus small colony variants (SCVs) are slow-growing morphological variants associated with persistent infections. While vancomycin activity has been shown to be attenuated against SCVs of S. aureus, few data exist regarding daptomycin. The objective was to evaluate...

  • Vancomycin-resistant staph: First in Japan, now here. Pinkowish, Mary Desmond // Patient Care;10/15/1997, Vol. 31 Issue 16, p171 

    Focuses on the report of a case of Staphylococcus aureus isolate with reduced susceptibility to vancomycin HCl in the United States. Details of the first known case of its kind; Reference to a Japanese report on the first incident of the vancomycin-resistant staph; Issue of interim guidelines...

  • Staphylococcus aureus with Reduced Susceptibility to Vancomycin--Illinois, 1999. Khurshid, M.A.; Chou, T. // MMWR: Morbidity & Mortality Weekly Report;1/7/2000, Vol. 48 Issue 51/52, p1165 

    Describes the case of a confirmed infection of Staphylococcus aureus with reduced susceptibility to vancomycin in a woman in Illinois in April 1999. Medical history of the patient; Drugs given to the patient; Cause of death of the patient.

  • Staphylococcus aureus Resistant to Vancomycin--United States, 2002.  // MMWR: Morbidity & Mortality Weekly Report;7/5/2002, Vol. 51 Issue 26, p565 

    Presents a report on the clinical isolate of vancomycin-resistant Staphylococcus aureus (VRSA) in the U.S. in 2002. Infections caused by Staphylococcus aureus; Details of a case of VRSA isolated from a patient; Methods used in identifying VRSA isolate from the patient.

  • Daptomycin/vancomycin.  // Reactions Weekly;2/5/2011, Issue 1337, p16 

    The article describes six cases of persistent or recurrent Staphylococcus aureus bacteraemia experienced by six patients despite vancomycin and subsequent daptomycin treatment.

  • Impact of the agr Quorum-Sensing System on Adherence to Polystyrene in Staphylococcus aureus. Cuong Vuong; Saenz, Henri L.; Gotz, Friedrich; Otto, Michael // Journal of Infectious Diseases;12/1/2000, Vol. 182 Issue 6 

    Biofilm formation by Staphylococcus aureus is a serious problem in nosocomial infections. There are great differences in the capacity of S. aureus to express biofilms, but the reasons are unknown. In all, 105 S. aureus strains were tested for a correlation between the agr quorum-sensing system...

  • Norway Stops Superbug.  // Current Science;4/16/2010, Vol. 95 Issue 15, p14 

    The article reports on the move of the Norwegian government to cut back on too much use of antibiotics for the treatment of Staphylococcus aureus infections (MRSA) among patients which have yielded into positive results and reduced the number of people infected by the bacteria.

  • Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus. Hübscher, Judith; Jansen, Andrea; Kotte, Oliver; Schäfer, Juliane; Majcherczyk, Paul A; Harris, Llinos G; Bierbaum, Gabriele; Heinemann, Matthias; Berger-Bachi, Brigitte // BMC Genomics;2007, Vol. 8, p1 

    Background: Synthesis of the Staphylococcus aureus peptidoglycan pentaglycine interpeptide bridge is catalyzed by the nonribosomal peptidyl transferases FemX, FemA and FemB. Inactivation of the femAB operon reduces the interpeptide to a monoglycine, leading to a poorly crosslinked peptidoglycan....

  • Activity of Fusidic Acid Against Extracellular and Intracellular Staphylococcus aureus: Influence of pH and Comparison With Linezolid and Clindamycin. Lemaire, Sandrine; Van Bambeke, Francoise; Pierard, Denis; Appelbaum, Peter C.; Tulkens, Paul M. // Clinical Infectious Diseases;2011, Vol. 52 Issue Suppl 7, pS493 

    Background. Emergence of multidrug-resistant Staphylococcus aureus has triggered a reassessment of fusidic acid (CEM-102, sodium fusidate).Methods. Fusidic acid was examined for (1) activity against recent methicillin-resistant S. aureus (MRSA) isolates; (2) modulation of activity by acidic pH;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics